Aleknagik South Side Clinic in Aleknagik South, AK - Clinic/Center

Aleknagik South Side Clinic is a primary clinic (Clinic/center) in Aleknagik South, Alaska. The current practice location for Aleknagik South Side Clinic is Main Street, Aleknagik South, Alaska. For appointments, you can reach them via phone at (907) 842-5201. The mailing address for Aleknagik South Side Clinic is Po Box 130, Dillingham, Alaska and phone number is (907) 842-5201.

Aleknagik South Side Clinic is licensed to practice in * (Not Available) (license number ) and its NPI number is 1740342286. This medical practice does not participate in medicare program and thus may not accept your medicare insurance. You may check if they accept your insurance at (907) 842-5201.

Contact Information

	Aleknagik South Side Clinic
	Main Street Aleknagik South AK 99555
	(907) 842-5201
	(907) 842-9250

Primary Care Clinic Profile

Full Name	Aleknagik South Side Clinic
Speciality	Clinic/center
Location	Main Street, Aleknagik South, Alaska
Authorized Official Name and Position	Robert Clark (CEO)
Authorized Official Contact	9078425201
Accepts Medicare Insurance	This clinic does not participate in Medicare Program.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Aleknagik South Side Clinic Po Box 130 Dillingham AK 99576-0130 Ph: (907) 842-5201	Aleknagik South Side Clinic Main Street Aleknagik South AK 99555 Ph: (907) 842-5201

NPI Details:

NPI Number	1740342286
Provider Enumeration Date	12/14/2006
Last Update Date	04/04/2013

Medical Identifiers

Medical identifiers for Aleknagik South Side Clinic such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1740342286	NPI	-	NPPES
TEZ154	Other	AK	MEDICARE ID- TYPE UNSPECIFIED

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
261Q00000X	Clinic/center	(* (Not Available))	Primary

News Archive

NK cells combined with bispecific antibody display potent anti-tumor activity against lymphoma cells

Cytokine-activated natural killer (NK) cells derived from donated umbilical cord blood, combined with an investigational bispecific antibody targeting CD16a and CD30 known as AFM13, displayed potent anti-tumor activity against CD30+ lymphoma cells, according to a new preclinical study from researchers at The University of Texas MD Anderson Cancer Center.

Simulations Plus announces release of MedChem Studio 2.0

Simulations Plus, Inc., a leading provider of simulation and modeling software for pharmaceutical discovery and development, announced today the release of MedChem Studio™ version 2.0 with an impressive set of expanded and powerful capabilities for data mining and de novo molecule design.

Researchers develop assessment tool to identify pain in nursing home residents with dementia

We know very little about the incidence of pain among the elderly in nursing homes. In Norway, no requirement is in place for pain to be assessed before or during nursing home admission, nor once a person has been admitted.

U.S. Customs to stop seizing Canadian drugs

U.S. Customs and Border Protection officials on Tuesday said that as of Oct. 9 they will no longer seize prescription drugs sent by mail to U.S. residents from Canadian pharmacies, the Wall Street Journal reports (Carreyrou, Wall Street Journal, 10/4).

Aleknagik South Side Clinic - Primary Care in Aleknagik South, AK